Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A 15-min premedication for 1-h paclitaxel infusion: optimizing patients' care.
Milani A, De Pas T, Noberasco C, McDonnell C, Libutti L, Limardi I, Zencovich C, Boselli S, Bianchi M, de Braud F. Milani A, et al. Among authors: boselli s. Lung Cancer. 2007 Nov;58(2):300-1. doi: 10.1016/j.lungcan.2007.08.009. Epub 2007 Sep 18. Lung Cancer. 2007. PMID: 17881082 Clinical Trial.
Simplified FOLFIRI in pre-treated patients with metastatic gastric cancer.
Lorizzo K, Fazio N, Radice D, Boselli S, Ariu L, Zampino MG, Nolè F, Magni E, Ardito R, Minchella I, Rocca A, Di Meglio G, Squadroni M, de Braud F. Lorizzo K, et al. Among authors: boselli s. Cancer Chemother Pharmacol. 2009 Jul;64(2):301-6. doi: 10.1007/s00280-008-0871-y. Epub 2008 Nov 26. Cancer Chemother Pharmacol. 2009. PMID: 19034450
Expression of gemcitabine- and cisplatin-related genes in non-small-cell lung cancer.
Toffalorio F, Giovannetti E, De Pas T, Radice D, Pelosi G, Manzotti M, Minocci D, Spaggiari L, Spitaleri G, Noberasco C, Catania C, Boselli S, Danesi R, de Braud F. Toffalorio F, et al. Among authors: boselli s. Pharmacogenomics J. 2010 Jun;10(3):180-90. doi: 10.1038/tpj.2009.53. Epub 2009 Nov 10. Pharmacogenomics J. 2010. PMID: 19901957
Safety, tolerability and biological effects of long-term metronomic administration of non-cytotoxic anti-angiogenic agents.
Noberasco C, Spitaleri G, Mancuso P, Zorzino L, Radice D, Milani A, Rocca A, Bertolini F, Sandri MT, Curigliano G, de Pas T, Jemos C, Omodeo Salè E, Boselli S, de Braud F. Noberasco C, et al. Among authors: boselli s. Oncology. 2009;77(6):358-65. doi: 10.1159/000275830. Epub 2010 Jan 11. Oncology. 2009. PMID: 20068365 Clinical Trial.
Phase I study of NGR-hTNF, a selective vascular targeting agent, in combination with cisplatin in refractory solid tumors.
Gregorc V, De Braud FG, De Pas TM, Scalamogna R, Citterio G, Milani A, Boselli S, Catania C, Donadoni G, Rossoni G, Ghio D, Spitaleri G, Ammannati C, Colombi S, Caligaris-Cappio F, Lambiase A, Bordignon C. Gregorc V, et al. Among authors: boselli s. Clin Cancer Res. 2011 Apr 1;17(7):1964-72. doi: 10.1158/1078-0432.CCR-10-1376. Epub 2011 Feb 9. Clin Cancer Res. 2011. PMID: 21307147 Clinical Trial.
Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study.
Joensuu H, De Braud F, Grignagni G, De Pas T, Spitalieri G, Coco P, Spreafico C, Boselli S, Toffalorio F, Bono P, Jalava T, Kappeler C, Aglietta M, Laurent D, Casali PG. Joensuu H, et al. Among authors: boselli s. Br J Cancer. 2011 May 24;104(11):1686-90. doi: 10.1038/bjc.2011.151. Epub 2011 May 3. Br J Cancer. 2011. PMID: 21540861 Free PMC article. Clinical Trial.
Optimizing clinical care in patients with advanced soft tissue sarcoma: a phase II study of a new schedule of high-dose continuous infusion ifosfamide and doxorubicin combination.
De Pas T, Rosati G, Spitaleri G, Boni C, Tucci A, Frustaci S, Scalamogna R, Radice D, Boselli S, Toffalorio F, Catania C, Noberasco C, Delmonte A, Vecchio F, de Braud F. De Pas T, et al. Among authors: boselli s. Chemotherapy. 2011;57(3):217-24. doi: 10.1159/000326466. Epub 2011 May 18. Chemotherapy. 2011. PMID: 21597285 Clinical Trial.
20 results